Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection

被引:55
作者
Cassaniti, Irene [1 ]
Colombo, Anna A. [2 ]
Bernasconi, Paolo [2 ]
Malagola, Michele [3 ]
Russo, Domenico [3 ]
Iori, Anna P. [4 ]
Girmenia, Corrado [4 ]
Greco, Raffaella [5 ]
Peccatori, Jacopo [5 ]
Ciceri, Fabio [5 ]
Bonifazi, Francesca [6 ]
Percivalle, Elena [1 ]
Campanini, Giulia [1 ]
Piccirilli, Giulia [7 ]
Lazzarotto, Tiziana [7 ]
Baldanti, Fausto [1 ,8 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Div Haematol, Hemopoiet Stem Cell Unit, Pavia, Italy
[3] Univ Brescia, Spedali Civili Brescia, Dept Clin & Expt Sci, Unit Blood Dis & Stem Cell Transplantat, Brescia, Italy
[4] Sapienza Univ, Azienda Policlin Umberto I, Dept Haematol Oncol & Dermatol, Rome, Italy
[5] IRCCS San Raffaele Sci Inst, Haematol & Bone Marrow Transplant Unit, Milan, Italy
[6] IRCCS Azienda Osped Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[7] Univ Bologna, St Orsola Polyclin, Operat Unit Clin Microbiol, Dept Specialized Expt & Diagnost Med, Bologna, Italy
[8] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy
关键词
clinical research/practice; infection and infectious agents - viral: Cytomegalovirus (CMV); infectious disease; molecular biology; molecular biology: DNA; translational research/science;
D O I
10.1111/ajt.16450
中图分类号
R61 [外科手术学];
学科分类号
摘要
Letermovir (LMV) inhibits HCMV replication by binding to components of the HCMV-terminase complex showing a potential role in prevention of HCMV-related complications in allogenic hematopoietic stem cell transplant recipients (allo-HSCTRs). However, little is known about breakthrough HCMV infection and the relevance of HCMV DNAemia during prophylaxis. We reported the results of a multicenter prospective study involving five Italian centers in the management of HCMV DNAemia in 75 adult HCMV-seropositive allo-HSCTRs undergoing LMV prophylaxis. The aim of the present study was to characterize the presence of real HCMV reactivation during LMV prophylaxis. Then, the presence of circulating infectious HCMV particles was determined by virus isolation and degradation of free-floating viral DNA. This report provides the first evidence that during LMV prophylaxis the clinical relevance of HCMV DNAemia should be critically considered.
引用
收藏
页码:1622 / 1628
页数:7
相关论文
共 18 条
[1]   Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation A Randomized Trial [J].
Boeckh, Michael ;
Nichols, W. Garrett ;
Chemaly, Roy F. ;
Papanicolaou, Genovefa A. ;
Wingard, John R. ;
Xie, Hu ;
Syrjala, Karen L. ;
Flowers, Mary E. D. ;
Stevens-Ayers, Terry ;
Jerome, Keith R. ;
Leisenring, Wendy .
ANNALS OF INTERNAL MEDICINE, 2015, 162 (01) :1-U132
[2]   Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients [J].
Camargo, Jose F. ;
Kimble, Erik ;
Rosa, Rossana ;
Shimose, Luis A. ;
Bueno, Maria X. ;
Jeyakumar, Nikeshan ;
Morris, Michele I. ;
Abbo, Lilian M. ;
Simkins, Jacques ;
Alencar, Maritza C. ;
Benjamin, Cara ;
Wieder, Eric ;
Jimenez, Antonio ;
Beitinjaneh, Amer ;
Goodman, Mark ;
Byrnes, John J. ;
Lekakis, Lazaros J. ;
Pereira, Denise ;
Komanduri, Krishna V. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) :806-814
[3]  
Chou SW, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.00922-18, 10.1128/AAC.00922-18]
[4]   Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation [J].
El Helou, Guy ;
Razonable, Raymund R. .
EXPERT OPINION ON DRUG SAFETY, 2019, 18 (11) :1017-1030
[5]   Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay [J].
Furione, Milena ;
Rognoni, Vanina ;
Cabano, Ermanna ;
Baldanti, Fausto .
JOURNAL OF CLINICAL VIROLOGY, 2012, 55 (04) :317-322
[6]   Targeting the terminase: An important step forward in the treatment and prophylaxis of human cytomegalovirus infections [J].
Gentry, Brian G. ;
Bogner, Elke ;
Drach, John C. .
ANTIVIRAL RESEARCH, 2019, 161 :116-124
[7]   In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients [J].
Gerna, G ;
Sarasini, A ;
Lilleri, D ;
Percivalle, E ;
Torsellini, M ;
Baldanti, F ;
Revello, MG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) :1639-1647
[8]   Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients [J].
Gerna, G ;
Vitulo, P ;
Rovida, F ;
Lilleri, D ;
Pellegrini, C ;
Oggionni, T ;
Campanini, G ;
Baldanti, F ;
Revello, MG .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (03) :408-416
[9]   Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies [J].
Girmenia, Corrado ;
Lazzarotto, Tiziana ;
Bonifazi, Francesca ;
Patriarca, Francesca ;
Irrera, Giuseppe ;
Ciceri, Fabio ;
Aversa, Franco ;
Citterio, Franco ;
Cillo, Umberto ;
Cozzi, Emanuele ;
Gringeri, Enrico ;
Baldanti, Fausto ;
Cavallo, Rossana ;
Clerici, Pierangelo ;
Barosi, Giovanni ;
Grossi, Paolo .
CLINICAL TRANSPLANTATION, 2019, 33 (10)
[10]   The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase [J].
Goldner, Thomas ;
Hewlett, Guy ;
Ettischer, Nicole ;
Ruebsamen-Schaeff, Helga ;
Zimmermann, Holger ;
Lischka, Peter .
JOURNAL OF VIROLOGY, 2011, 85 (20) :10884-10893